Literature DB >> 16580781

Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.

J L Smith1, S Xiong, W R Markesbery, M A Lovell.   

Abstract

Accumulating evidence suggests that a disruption of zinc (Zn) homeostasis may play a role in the pathogenesis of Alzheimer's disease. Although several Zn transporter proteins responsible for the regulation of Zn balance are present in the brain, there has been little study of these proteins in Alzheimer's disease. To determine if alterations of Zn transporter proteins exist, levels of Zn transporter-4, which functions to remove Zn from the cytoplasm to endosomal/lysosomal compartments, and Zn transporter-6, which allocates cytoplasmic Zn to the trans-Golgi network, were measured in the hippocampus/parahippocampal gyrus, superior and middle temporal gyrus, and cerebellum of subjects with mild cognitive impairment, early Alzheimer's disease, late stage Alzheimer's disease, and age-matched controls using Western blot analysis and protein specific antibodies. Our results show that Zn transporter-4 and Zn transporter-6 are significantly (P<0.05) increased in hippocampus/parahippocampal gyrus of early Alzheimer's disease and Alzheimer's disease subjects. Zn transporter-6 is also increased (P<0.1) in the superior and middle temporal gyrus of Alzheimer's disease brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580781     DOI: 10.1016/j.neuroscience.2006.02.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  31 in total

Review 1.  Mechanism and regulation of cellular zinc transport.

Authors:  Israel Sekler; Stefano L Sensi; Michal Hershfinkel; William F Silverman
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

2.  Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain.

Authors:  Ganna Lyubartseva; Jennifer L Smith; William R Markesbery; Mark A Lovell
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

3.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

Review 4.  A potential role for zinc alterations in the pathogenesis of Alzheimer's disease.

Authors:  Ganna Lyubartseva; Mark A Lovell
Journal:  Biofactors       Date:  2012-03-23       Impact factor: 6.113

5.  A New «off-on» Fluorescence Zinc Ion Sensors Based on Iodo- and Bromosubstituted Dipyrromethenes.

Authors:  Ekaterina N Nuraneeva; Galina B Guseva; Elena V Antina
Journal:  J Fluoresc       Date:  2021-01-07       Impact factor: 2.217

6.  Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing.

Authors:  Xiao-An Zhang; Katherine S Lovejoy; Alan Jasanoff; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

7.  Serum zinc in the progression of Alzheimer's disease.

Authors:  Jiang Dong; J David Robertson; William R Markesbery; Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

8.  Zinc toxicity to aminergic neurotransmitters in rat brain.

Authors:  M Vijaya Kumar; B Nirmala Kumari; K Yellamma
Journal:  Toxicol Int       Date:  2010-07

Review 9.  A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease.

Authors:  Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain.

Authors:  Nancy Beyer; David Tr Coulson; Shirley Heggarty; Rivka Ravid; G Brent Irvine; Jan Hellemans; Janet A Johnston
Journal:  Mol Neurodegener       Date:  2009-12-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.